Drug
Ruxoprubart clinical trials
Also written NM8074.
Keep track of what changes. Save the ruxoprubart studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
- NM8074
- 9
Studies by the year they started
5 studies that test it; most in 2026 (4); 4 more planned to start later
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 0
NovelMed Therapeutics (9)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses ruxoprubart is read from its arms, and is right about nine times in ten.
Testing it · 9
- Study of NM8074 in Adult PNH Patients With Inadequate Response to SolirisNot yet recruitingPhase 2NovelMed TherapeuticsNCT05646563Written as NM8074
- Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN)Not yet recruitingPhase 2NovelMed TherapeuticsNCT06454110Written as NM8074
- Study of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic MicroangiopathyNot yet recruitingPhase 2NovelMed TherapeuticsNCT05684159Written as NM8074
- Study of NM8074 in Adult C3 Glomerulopathy PatientsNot yet recruitingPhase 1/2NovelMed TherapeuticsNCT05647811Written as NM8074
- Study of NM8074 in Soliris-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)Not yet recruitingPhase 2NovelMed TherapeuticsNCT05731050Written as NM8074
- Study of NM8074 in Patients with Dermatomyositis (DM)Not yet recruitingPhase 2NovelMed TherapeuticsNCT06887738Written as NM8074
- Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)Not yet recruitingPhase 2NovelMed TherapeuticsNCT06226662Written as NM8074
- Study of Efficacy and Safety of NM8074 in Adult PNH Patients Who Are Naive to Complement Inhibitor TherapyNot yet recruitingPhase 2NovelMed TherapeuticsNCT05646524Written as NM8074
- First-in-Human (FIH) Clinical Study of NM8074 in Healthy Adult VolunteersCompletedPhase 1NovelMed TherapeuticsNCT05642546Written as NM8074
Codes
What other systems call ruxoprubart · ClinicalTrials.gg INT017560
- UNII (FDA) P9NB0SOG5XRUXOPRUBARTOne source FDA
- NCI Thesaurus C199294RuxoprubartOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | P9NB0SOG5X | RUXOPRUBART | One source FDA |
| NCI Thesaurus | C199294 | Ruxoprubart | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.